IL6 and cancer: In contrast, the role of estrogen as an anti-inflammatory agent has also been documented in several cancers, including that of the liver (incidence ratio between men versus women ranges from 2:1 to 4:1), where estrogen inhibits the production of the inflammatory cytokine interleukin 6 (IL-6) [10].